Telix Pharmaceuticals Limited (ASX:TLX)
Australia · Delayed Price · Currency is AUD 15.01
-0.15 (-0.99%)
Nov 7, 2025, 4:12 PM AEST
Telix Pharmaceuticals Market Cap
Telix Pharmaceuticals has a market cap or net worth of 5.08 billion as of November 7, 2025. Its market cap has decreased by -29.27% in one year.
Market Cap
5.08B
Enterprise Value
5.40B
Revenue
1.01B
Ranking
n/a
PE Ratio
230.79
Stock Price
15.01
Market Cap Chart
Since November 15, 2017, Telix Pharmaceuticals's market cap has increased from 152.03M to 5.08B, an increase of 3,241.69%. That is a compound annual growth rate of 55.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 5.08B | -38.33% |
| Dec 31, 2024 | 8.24B | 152.44% |
| Dec 29, 2023 | 3.26B | 41.89% |
| Dec 30, 2022 | 2.30B | 4.10% |
| Dec 31, 2021 | 2.21B | 108.44% |
| Dec 31, 2020 | 1.06B | 169.99% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 15, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 86.53B |
| Pro Medicus | 26.40B |
| Cochlear | 18.63B |
| Sonic Healthcare | 10.33B |
| Ramsay Health Care | 7.09B |
| Ansell | 5.18B |
| Mesoblast | 2.85B |
| Neuren Pharmaceuticals | 2.35B |